Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Nov 19 424B4 Prospectus supplement with pricing info
- 21 Nov 19 EFFECT Notice of effectiveness
-
18 Nov 19 S-1 IPO registration
KRTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Karuna Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP |
Cambridge, Massachusetts November 18, 2019 |